14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
EMR vs ADP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Emerson Electric Co. (EMR) is the stronger overall head-to-head candidate over Automatic Data Processing (ADP) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). EMR carries a Unified Composite Score of 51.2/100 (HOLD) at $161.06 (22.9x Forward P/E, 24.8% operating margin), whereas ADP carries 41.6/100 (SELL) at $313.83 (25.4x Forward P/E, 26.7% operating margin).
Competes within the Specialty Industrial Machinery value chain with $91.6B market capitalization and 24.8% operating margin.
OpEx & R&D Reinvestment27.9% of Rev ($5.30B)
90D Engineering Disclosures0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing CompanyAmkor TechnologyASE Technology HoldingCadence Design Systems
ADP Moat ProfileHigh-Margin Pricing Power Moat
Software - Application Operator
Competes within the Software - Application value chain with $121.6B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment22.1% of Rev ($4.92B)
90D Engineering Disclosures0 Published
Investor FAQ EMR vs ADP Key Questions & Quantitative Answers
As of Nov 16, 2026, Emerson Electric Co. (EMR) is the stronger overall head-to-head candidate over Automatic Data Processing (ADP) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). EMR carries a Unified Composite Score of 51.2/100 (HOLD) at $161.06 (22.9x Forward P/E, 24.8% operating margin), whereas ADP carries 41.6/100 (SELL) at $313.83 (25.4x Forward P/E, 26.7% operating margin). Technically, EMR sits in a Neutral phase (RSI 46.2, CONSOLIDATION options structure) and ADP sits in a Markup phase (RSI 69.8, CONSOLIDATION options structure).
EMR leads the Growth & Scale pillar: EMR posts +7.1% YoY revenue growth and +23.8% YoY earnings growth on $19.0B TTM revenue (52.7% gross margin, 24.8% operating margin), compared with ADP at +6.1% YoY revenue growth and +13.7% YoY earnings growth on $22.3B TTM revenue (48.8% gross margin, 26.7% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), EMR cumulative revenue shifted +3.3% while ADP shifted +55.6%. In operating R&D and SG&A reinvestment, EMR deploys 27.9% of Rev ($5.30B) (0 90-day corporate R&D disclosures) versus 22.1% of Rev ($4.92B) (0 disclosures) for ADP.
EMR screens cheaper on headline valuation multiples. EMR trades at 22.9x Forward P/E, 34.9x Trailing P/E, 2.02x PEG, and 5.4x EV/Revenue (18.6% FCF margin), whereas ADP trades at 25.4x Forward P/E, 27.3x Trailing P/E, 2.82x PEG, and 5.5x EV/Revenue (21.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EMR (13.1% ROE) versus ADP (78.9% ROE) capital efficiency.
In options market volatility and institutional positioning, EMR carries 46.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.40x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.45β · 34% Vol realized risk). By comparison, ADP carries 47.9% implied volatility (39th %ile, Balanced (25th–60th %ile)), a 0.29x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.35β · 28% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.